Literature DB >> 28270875

Prevalence of Helicobacter pylori Infection in Samples of Gastric Biopsies.

Leda Maria Delmondes Freitas Trindade1, Lania Barreto de Oliveira Menezes1, Adozina Marques de Souza Neta1, Paulo Candido Leite Rolemberg1, Lais Dantas Souza1, Ikaro Daniel de Carvalho Barreto2, Luise Meurer3.   

Abstract

BACKGROUND: Helicobacter pylori (H. pylori) infection affects about 50% of the world population and its association with environmental factors and host properties is involved in gastric carcinogenesis. The study aimed to estimate the prevalence of H. pylori in samples of gastric mucosa biopsies, correlate the presence of the bacteria in the sample with the variables age, sex and origin, to identify the types of lesions found in patients with H. pylori, and to evaluate the association of the lesions with the region of the gastric mucosa.
METHODS: A cross-sectional, retrospective study was carried out in Aracaju, Sergipe, Brazil, from January 2013 to December 2015. A total of 45,206 gastric mucosal biopsies were obtained from patients submitted to upper gastrointestinal endoscopy. Of the reports evaluated, 12,909 met the inclusion criteria since they presented the patient's demographic data as well as the histopathological characteristics of gastric mucosal regions and positivity for H. pylori. Data were analyzed by IBM SPSS Statistic 20 and subjected to descriptive analyses (categorical variables) and inferential (Pearson's Qui-square and linear association tests) and multiple correspondence analyses. Significance level adopted 5%.
RESULTS: Of the total of 12,909 (28.6%) reports evaluated, 67% (8,647) came from urban areas and 64.5% (8,320) were female. The mean age (standard deviation (SD)) was 43 years, ranging from 8 to 100 years, prevailing between 21 and 60 years. Among the types of gastric mucosa analyzed, 95.5% (12,322) were of the antral mucosa. The absence of glandular atrophy, the mild infection intensity for H. pylori, the absence of metaplasia, the presence of foveolar hyperplasia and lymphoid follicles were statistically significant (P < 0.001) in this region. In the fundic region, the evidence of fibrinoleucocytic crust and lymphoid follicles was significant (P < 0.001). There was no evidence of associated ulcerated lesions or significant relationship with intestinal metaplasia in the antral mucosa, whereas the fundic mucosa had a strong association with lymphoid follicles. The prevalence of active H. pylori infection in this study was 30.93%.
CONCLUSION: Detection rate of H. pylori and its association with acute and chronic inflammation should be taken into account. The antral region has shown higher incidence and the presence of H. pylori was strongly associated with foveolar hyperplasia and lymphoid follicles.

Entities:  

Keywords:  Atrophy; Gastric mucosa; Helicobacter pylori; Intestinal metaplasia; Prevalence of Helicobacter pylori

Year:  2017        PMID: 28270875      PMCID: PMC5330691          DOI: 10.14740/gr785w

Source DB:  PubMed          Journal:  Gastroenterology Res        ISSN: 1918-2805


Introduction

For over 100 years, micro-organisms have been observed in the gastric tissue, and its association with gastritis has been known since the 1970s. In 1982, Marshall and Warren identified and cultivated Campylobacter pyloridis, later called Helicobacter pylori (H. pylori) [1]. H. pylori is a spiral-shaped gram-negative and microaerophilic [2]. Its ability to proliferate and survive in the gastric environment is due to factors such as the production of urease by the microorganism, its motility and ability to adhere to the gastric epithelium. The way through which the infection occurs remains unknown. However, person to person transmission appears to be the most likely one, either through fecal-oral or oral-oral exposure [3]. Conservative approaches to this issue suggest that 50% of the population is affected by H. pylori and it is considered the commonest bacterial infection in humans [4]. Genetic sequencing analysis suggests that humans have been infected with H. pylori since their first migration from Africa some 58,000 years ago [5]. Once acquired, the infection persists and may or may not produce gastroduodenal disease [3]. The prevalence of the infection varies according to age, socioeconomic status and ethnicity. Socioeconomic status is also an important determinant and inversely correlated to H. pylori infection [6]. Furthermore, within any age range, the infection appears to be more common amongst blacks and Hispanics compared to whites [7]. In developing countries, where most children are infected before the age of 10, the prevalence in adults reaches more than 80% before aged 50. In developed countries, like the United States, the evidence of the infection among children is very unlikely to happen, but it becomes more common during adulthood [7]. The increase in the prevalence of infection with age was initially thought to represent a continuous rate of acquisition of the bacterium throughout the life. However, new epidemiological evidence indicates that most infections are acquired during childhood, even in developed countries [7]. Recent studies [6] suggest that, in developing countries, such as Iran, hygiene practices in childhood and family education determine the prevalence of the infection. In Japan, from 1950 on, there was a rapid decline of the infection rate attributed to the economic progress of the post-war period and improved sanitation [8]. The quality of life and socioeconomic conditions should be considered risk factors to acquire H. pylori infection [9]. The chronic inflammation induced by H. pylori interferes with the normal physiology of the gastric acid secretion in different degrees, thus leading to chronic gastritis, which, in most individuals, remains asymptomatic and does not progress. However, in some cases, altered gastric secretion, associated with tissue injury, induces the development of peptic ulcer, whereas in other cases, gastritis progresses to atrophy, intestinal metaplasia, and eventually to gastric carcinoma or rarely to gastric lymphoma, due to the persistent immune stimulation of the lymphoid tissue [10]. The gastritis can be classified based on the severity of the mucosal lesion as erosive or non-erosive, according to the site of gastric involvement (cardia, body and antrum) and histologically, as acute or chronic based on the type of inflammatory cell. However, no classification scheme fits perfectly into pathophysiology, and the evolution of gastric atrophy involves different clinical and pathophysiological consequences. Gastric gland atrophy may be present in several lesions, especially gastritis, which can progress to the multifocal gastritis associated with the bacterium H. pylori and atrophic gastritis of the body, not dependent on the presence of the bacterium [11]. In view of the above, it is necessary to identify the prevalence with H. pillory infection, independently of associated lesions, in order to discuss these aspects with the purpose of contributing to their reduction. The study aimed to: 1) determine the prevalence of H. pylori in samples of gastric mucosa biopsies (antrum, body, cardia and fundus), obtained through upper digestive endoscopy and original reports of surgical pathology in a pathology laboratory Aracaju, Sergipe, Brazil; 2) correlate the presence of H. pylori in gastric biopsy material with the variables such as age, region (urban versus rural) and sex; 3) identify the types of lesions found in gastric mucosa with H. pylori positive; and 4) evaluate the association of the lesions found with the biopsied gastric mucosal region.

Methodology

Between January 2013 and December 2015, a cross-sectional, retrospective study was performed at the Laboratory of Pathological Anatomy Dra. Monica Araujo (LAPMA), in Aracaju, Sergipe, based on the analysis of gastric mucosa reports obtained through biopsies of gastric mucosa from body, antrum, cardia and fundus, with H. pylori infection, regardless of whether through endoscopy and/or specimens of surgical resection. Reports from specimens of surgical resection were excluded because they presented incomplete information. During the research period, 45,206 biopsies were performed for the study of H. pylori from endoscopic gastric mucosa biopsy. Of this total, 13,986 reports were evaluated because they presented a positive result for the bacterium, and 1,077 were excluded because they did not meet the inclusion criteria, i.e., all reports should present the patients’ demographic data, histopathological characteristics of the biopsied regions of the gastric mucosa and positivity for H. pylori. The final sample consisted of 12,909 biopsy reports. A questionnaire was used as a data collection tool to identify the anatomopathological profile of the mucosa, which consisted of a tab with multiple-choice and short-text questions, elaborated by the researchers, having as dependent variable, the existence of H. pylori and independent variables: the patients’ demographic characteristics (name, age, urban vs. rural region and sex); the histopathological characteristics of the antrum, fundus, cardia and body regions of the gastric mucosa such as the presence of chronic inflammation and inflammatory activity; glandular atrophy; intestinal metaplasia; evidence of ulcerated lesion; presence of fibrinoleukocytic crust, foveolar hyperplasia, lymphoid follicles, granulomas and other alterations, and the intensity of H. pylori colonization. The degree of intestinal metaplasia, classification of glandular atrophy and intensity of H. pylori colonization were performed according to the Sydney System [11]. The histological diagnosis of gastritis with and without H. pylori infection based on the Sydney System allowed to classify it histologically and to identify its topographic distribution from gastric biopsy. As for the methodology used for the staining of the gastric biopsy fragments, for the histological examination, the fragments were deposited in bottles identified topographically, containing 10% formalin solution and led to a routine histological process, then subjected to 5 μm cuts and stained with hematoxylin-eosin and Giemsa. To analyze the data, descriptive and inferential analyses were performed. In the descriptive ones, the categorical variables were presented by means of simple frequency and percentage, as for the continuous ones, through mean and standard deviation (SD). In the inferential analysis, Pearson’s Chi-square association and line tests were used. In order to evaluate the histopathological profile of the biopsied regions of the gastric mucosa, the perceptual map was constructed from the multiple correspondence analyses. The significance level adopted was 5% and the software used for the analysis was IBM SPSS Statistics 20.0. The study was approved by the Committee of Ethics and Research of the Universidade Tiradentes-CEP/UNIT (CAAE: 49195515.4.0000.5371).

Results

Endoscopic gastric biopsies totaled a sample of 45,206 biopsies. Of the total sample, 13,986 were H. pylori positive, which translates into a prevalence of 30.93% (45,206). For data analysis, 12,909 reports met the inclusion criteria. Regarding sociodemographic variables, 8,320 (64.5%) of the samples were female and 4,589 (35.5%) were male. Of the samples, 8,647 (72.3%) were from urban areas. The mean age (SD) was 43 years (14.5%), and the age range of the sample varied from 8 to 100 years, being more prevalent between 21 and 60 years (Fig. 1).
Figure 1

Age group of patients with positive H. pylori infection.

Age group of patients with positive H. pylori infection. As for the prevalence of gastric mucosa types and levels of infection, the antral mucosa was stated to appear the most representative fragment, corresponding to 95.5% (12,322) of the samples. It was also observed that 45.4% (5,857) of them had mild infection and 43.3% (5,587) presented moderate infection levels (Table 1).
Table 1

Prevalence of Gastric Mucosa Types Represented in the Study and Levels of H. pylori Infection

N%
Mucosa type
  Antrum12,32295.5
  Fundus6,05846.9
  Antrum and fundus5,50442.6
  Cardia30.02
  Body620.5
  Antral-fundic transition750.6
H. pylori infection levels
  Mild5,85745.4
  Moderate5,58743.3
  Severe1,46511.3
The lesions were characterized as: glandular atrophy, intestinal metaplasia (specialized glands of the gastric body are replaced by intestinal type cells), ulcerations (gastric and duodenal ulcers), fibrinoleucocytic crust, foveolar hyperplasia, lymphoid follicles, granulomas, in addition to chronic inflammation and evidence of inflammatory activity. The absence of glandular atrophy was observed in 93.2% (12,033) of the biopsies. The mild type level of angular atrophy appeared in 6.1% (793) of the samples. In this study, 89.5% (11,548) of the cases had no intestinal metaplasia. In the 10.5% of cases with intestinal metaplasia, focal type was the most frequent when compared to diffuse and multifocal metaplasia. Some of the histologic features examined in this study were shown in Figures 2 and 3.
Figure 2

Histological section of gastric mucosa with H. pylori chronic gastritis. (A) Gastritis. (B) Inflammatory activity. (C) Oxyntic mucosal gastritis. (D) Lymphoid follicle (arrow) (H&E, × 100).

Figure 3

Antral mucosa with intestinal metaplasia (H&E, × 100).

Histological section of gastric mucosa with H. pylori chronic gastritis. (A) Gastritis. (B) Inflammatory activity. (C) Oxyntic mucosal gastritis. (D) Lymphoid follicle (arrow) (H&E, × 100). Antral mucosa with intestinal metaplasia (H&E, × 100). The presence of lymphoid follicles was more often observed compared to other alterations found (gastric and duodenal ulceration, fibrinoleucocytic crust, presence of foveolar hyperplasia and granulomas) (Table 2).
Table 2

Histopathologic Findings of the Gastric Mucosa in Patients With Positive H. pylori Infection

N%
Glandular atrophy
  Absent12,03393.23
  Mild7936.14
  Moderate750.58
  Severe50.04
Metaplasia classification
  Absent11,54889.5
  Focal9397.3
  Multifocal3102.4
  Diffuse1120.9
Evidence of ulcerated injury5384.2
Fibrinoleukocytic crust2892.2
Foveolar hyperplasia2,03315.7
Lymphoid follicles8,00162
Granulomas230.2
Regarding the relationship between the inflammatory process and the biopsied regions of the gastric mucosa, in all the regions evaluated, there was predominance of moderate degree, both in chronic inflammation and in the presence of inflammatory activity (Table 3).
Table 3

Correlation Between Inflammation and Biopsied Gastric Regions in Patients With Positive H. pylori Infection

Antral
Fundus
Cardia
Body
Antral-fundic transition
N%N%N%N%N%
Chronic inflammation
  Absent50.04911.50011.600
  Mild1,59912.971,32421.9002031.722.7
  Moderate8,33567.643,87564266.74165.15674.7
  Severe2,38319.3376812.7133.311.61722.7
Inflammatory activity
  Absent5064.15148.50069.779.3
  Mild4,934402,49541.2133.32540.33141.3
  Moderate6,02448.92,80946.3133.33048.43242.7
  Severe8587.02404133.311.656.7
Comparing the histopathological findings between the antrum and other regions of the stomach, the antral region has a higher rate (P < 0.001) of glandular atrophy, H. pylori infection level, presence of foveolar hyperplasia and lymphoid follicles (Table 4).
Table 4

Correlation Between Histopathological Findings of Antral Region and Other Locations of the Gastric Mucosa in H. pylori Positive Patients

Antral
Others regions
X2 (P-value)
N%N%
Glandular atrophy
  Absent11,45392.9758098.825.8 (< 0.001)*
  Mild7886.4050.9
  Moderate730.5920.3
  Severe50.0400
H. pylori search
  Mild (+/3+)5,5394531854.127.4 (< 0.001)*
  Moderate (++/3+)5,35343.423439.9
  Severe (+++/3)1,43011.6356
Metaplastic classification
  Absent10,97589.157397,643.5 (< 0.001)
  Focal1110.910.2
  Multifocal9287.5111.9
  Diffuse3082.520.3
Evidence of ulcerated injury5284.3101.79.3 (0.002)
Fibrinoleucocytic crust2792.3101.70.80 (0.370)
Foveolar hyperplasia1,99716.2366.142.8 (< 0.001)
Lymphoid follicles7,78063.122137.6154 (< 0.001)
Granulomas220.0210.020.002 (0.963)

X2: Chi-square test. *Linear association.

X2: Chi-square test. *Linear association. In the fundic region, an evidence of fibrinoleucocytic crust and lymphoid follicles were significant (P < 0.001) when compared to other regions of the gastric mucosa (Table 5).
Table 5

Correlation Between Histopathological Findings of Fundus and Other Locations of the Gastric Mucosa in H. pylori Positive Patients

Fundus
Other regions
X2 (P-value)
N%N%
Glandular atrophy
  Absent5,68893.926,34592.639.6 (0.002)*
  Mild3395.604546.63
  Moderate270.45480.7
  Severe20.0330.04
H. pylori infection levels
  Mild (+/3+)2,80746.33,05044.55.6 (0.018)*
  Moderate (++/3+)2,59542.82,99243.7
  Severe (+++/3+)65610.880911.8
Metaplastic classification
  Absent5,451906,097895.7 (0.127)
  Focal550.9570.8
  Multifocal42475157.5
  Diffuse1282.11822.7
Evidence of ulcerated injury2574.22814.10.16 (0.690)
Fibrinoleucocytic crust971.61922.821.2 (< 0.001)
Foveolar hyperplasia1,01516.81,01814.58.7 (0.003)
Lymphoid follicles3,98465.84,01758.669.3 (< 0.001)
Granulomas150.280.13.09 (0.079)

X2: Chi-square test. *Linear association.

X2: Chi-square test. *Linear association. Through the multiple correspondence analyses, the anatomopathological profile of the antral and fundic mucosa was observed due to the proximity between the objects. In the antral mucosa, in addition to the presence of H. pylori degrees of mild to moderate, there was significant relationship with the absence of glandular atrophy, absence of associated ulcerated lesions and absence of intestinal metaplasia (Fig. 4).
Figure 4

Pathological profile of the antral mucosa.

Pathological profile of the antral mucosa. Fundic mucosa displayed a strong association with the lymphoid follicles, partially linked to the mild and moderate levels of H. pylori infection, partially associated with the absence of glandular atrophy and absence of foveolar hyperplasia (Fig. 5).
Figure 5

Pathological profile of the fundic mucosa.

Pathological profile of the fundic mucosa.

Discussion

Evidence estimates that 50% of the world population is affected by H. pylori. It is considered the commonest bacterial infection in humans [12, 13]. The prevalence of infection varies from age to age, ethnicity and especially socioeconomic status which is an important determinant and inversely correlated with the infection [4, 6]. The present study displayed a H. pylori infection prevalence of 30.93%. Previous studies [14-16] ranged from 26.91% to 76% in prevalence putting the present study close to the lower range point. Although the literature points out that H. pylori serum-prevalence is equally distributed in men and women, in this study, females had a higher prevalence, and the mean age of the infected was 43 years [13, 17]. The predominant age group ranged from 21 to 60 years (83%), whereas in developed countries, such as the United States, serologic values ??of H. pylori are rarely found before the age of 10. Between the age of 18 and 30, these values reach 10% and increase to 50% in people over 60 [4]. In developing nations, where most children are infected before the age of 10, the prevalence in adults reaches more than 80% before the age of 50 [4]. In Brazil, Bedoya et al [18] made a comparison with several diagnostic tests and reported a prevalence of 34% in children and young people up to 18 years old, increasing significantly over aging process. Evaluating the level of intensity regarding the presence of H. pylori in the biopsied material, it was found that the mild and moderate levels predominated in all gastric regions. No studies supporting these findings could be found in literature. The pathological profile of the gastric mucosa displayed presence of chronic inflammation and inflammatory activity in a moderated level in almost all biopsied regions, except for the region of the cardia, in relation to the inflammatory activity. According to Hagymasi et al [19], H. pylori-induced continuous inflammation, usually confined to the antrum, alters the physiology of gastric acid secretion to varying degrees, leading to chronic gastritis, which in most individuals does not further evolve. Evidence points out that chronic gastritis induced by H. pylori affects the stomach’s antrum and body mucosa in most of the cases [20, 21]. A study conducted in Brazil by Alvares et al [22] identified a prevalence of 88.4% of chronic gastritis in H. pylori positive patients, with significantly more inflammation in the antrum and angular incisure than in the gastric body. In the present study, evidence of ulcerated lesions was found in 4.2% of the H. pylori positive samples evaluated. Antral and fundic regions presented similar results, with a prevalence of 4.3% and 4.2%, respectively. Odze and Goldblum [23] stated that although H. pylori infects more than half of the world’s population, only 1-3% of the patients infected develop gastric adenocarcinoma. Therefore, a prevalence of glandular atrophy and intestinal metaplasia in the samples was evaluated. Glandular atrophy was absent in 93.2% of the H. pylori positive samples. Gastric intestinal metaplasia defined as the replacement of the surface, foveolar and glandular epithelium in the oxyntic or antral mucosa by the intestinal epithelium was absent in 89.5% of the samples. Lymphoid follicles appear within a week after the onset of acute H. pylori infection, and are unusual on healthy/uninfected gastric mucosa [24]. Histopathological changes like foveolar hyperplasia and lymphoid follicles have shown, in the analyzed samples, a significant association with H. pylori. However, the evidence of ulcerated lesions in the antral region and fundic region did not support the idea that the presence of H. pylori represents significant development of either type of ulcerated lesion. The data showed that the lymphoid follicles were evidenced in 62% of the H. pylori positive gastric biopsy samples, evidenced the hypothesis of an important link between lymphoid follicles and infection [25]. The presence of foveolar hyperplasia in the gastric mucosa occurs in patients with normal histological presentation of gastric mucosa. It may, however, be a consequence of chronic inflammation and its association with H. pylori [26]. This finding had significant value (P < 0.001) in both the antrum and fundic regions. It is known that H. pylori infection is characterized by a transient increase in acid secretion and hypochlorhydria, being a precursor for the development of active chronic gastritis, with a dense cellular infiltrate in the mucosa, which due to its persistence can cause serious damage to the gastric mucosa, which can progress to atrophic gastritis, glandular atrophy and intestinal metaplasia. The infection by the micro-organism is characterized by chronicity, which predisposes its participation in the pathogenesis of chronic gastritis, peptic ulcers (gastric and duodenal), adenocarcinoma, gastric lymphoma and recurrent abdominal pain.
  22 in total

1.  Spotlight on gastroenterology - the Nobel Prize Laureates in Physiology or Medicine 2005: John Robin Warren and Barry James Marshall.

Authors:  Per M Hellström
Journal:  Scand J Gastroenterol       Date:  2005-12       Impact factor: 2.423

2.  Prevalence of Helicobacter pylori infection and its relation with body mass index in a Chinese population.

Authors:  Chengfu Xu; Ming Yan; Yan Sun; Jungsoo Joo; Xingyong Wan; Chaohui Yu; Qunyan Wang; Chao Shen; Peng Chen; Youming Li; William G Coleman
Journal:  Helicobacter       Date:  2014-09-25       Impact factor: 5.753

Review 3.  Diagnosis and epidemiology of Helicobacter pylori infection.

Authors:  Xavier Calvet; María-José Ramírez Lázaro; Philippe Lehours; Francis Mégraud
Journal:  Helicobacter       Date:  2013-09       Impact factor: 5.753

4.  Foveolar hyperplasia at the gastric cardia: prevalence and associations.

Authors:  M Voutilainen; M Juhola; M Färkkilä; P Sipponen
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

Review 5.  The updated Sydney system: classification and grading of gastritis as the basis of diagnosis and treatment.

Authors:  M Stolte; A Meining
Journal:  Can J Gastroenterol       Date:  2001-09       Impact factor: 3.522

Review 6.  The inflammatory and immune response to Helicobacter pylori infection.

Authors:  Karen Robinson; Richard H Argent; John C Atherton
Journal:  Best Pract Res Clin Gastroenterol       Date:  2007       Impact factor: 3.043

Review 7.  Gastroduodenal peptic ulcer and Helicobacter pylori infection in children and adolescents.

Authors:  Paulo F S Bittencourt; Gifone A Rocha; Francisco J Penna; Dulciene M M Queiroz
Journal:  J Pediatr (Rio J)       Date:  2006-09-19       Impact factor: 2.197

8.  Diagnosis and Treatment of Peptic Ulcer Disease and H. pylori Infection.

Authors:  Julia Fashner; Alfred C Gitu
Journal:  Am Fam Physician       Date:  2015-02-15       Impact factor: 3.292

9.  Association of Helicobacter pylori infection and environmental factors in non-cardia gastric cancer in Japan.

Authors:  Ai Machida-Montani; Shizuka Sasazuki; Manami Inoue; Syusuke Natsukawa; Kozo Shaura; Yoichi Koizumi; Yoshio Kasuga; Tomoyuki Hanaoka; Shoichiro Tsugane
Journal:  Gastric Cancer       Date:  2004       Impact factor: 7.370

Review 10.  Helicobacter pylori infection: An overview of bacterial virulence factors and pathogenesis.

Authors:  Cheng-Yen Kao; Bor-Shyang Sheu; Jiunn-Jong Wu
Journal:  Biomed J       Date:  2016-04-01       Impact factor: 4.910

View more
  2 in total

1.  The Relation Between Host TLR9 -1486T/C, rs187084 Gene Polymorphisms and Helicobacter pylori cagA, sodB, hsp60, and vacA Virulence Genes among Gastric Cancer Patients.

Authors:  Amira M Sultan; Ragy Shenouda; Ahmad M Sultan; Ahmed Shehta; Yasmin Nabiel
Journal:  Pol J Microbiol       Date:  2022-02-27

2.  Evaluation of mutagenesis, necrosis and apoptosis induced by omeprazole in stomach cells of patients with gastritis.

Authors:  Ana Maria Oliveira Ferreira da Mata; Marcia Fernanda Correia Jardim Paz; Ag-Anne Pereira Melo de Menezes; Antonielly Campinho Dos Reis; Bruna da Silva Souza; Carlos Dimas de Carvalho Sousa; Sônia Alves Machado; Thiago Soares Gondim Medeiros; Chandan Sarkar; Muhammad Torequl Islam; Javad Sharifi-Rad; Sevgi Durna Daştan; Mohammed M Alshehri; João Marcelo de Castro E Sousa; Ana Amélia de Carvalho Melo Cavalcante
Journal:  Cancer Cell Int       Date:  2022-04-18       Impact factor: 6.429

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.